SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (29624)12/14/1999 9:59:00 AM
From: bob zagorin  Read Replies (2) | Respond to of 32384
 
Henry, on Friday you predicted the meeting would go "fairly smoothly". Were you surprised by the controversy over the trials and the rejection of the early stage treatments? I guess I wouldn't say it went fairly smoothly and the market seems to agree right now.



To: Henry Niman who wrote (29624)12/14/1999 10:50:00 AM
From: WTDEC  Read Replies (3) | Respond to of 32384
 
Henry,

David Molowa at Bear Stearns issued an optimistic report this morning and reiterated his buy recommendation with a $20 price target. He noted that momentum investors are probably bailing and that it is creating an excellent buying opportunity.

David felt that going for 'early stage CTCL' approval was a real long shot, so he is not at all surprised by the outcome.

Best regards,

Walter


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News